Codify — Article

Lowering Health Care Costs for Americans Act (S.3389): subsidies, HSAs, and transparency

Rewrites subsidy delivery, creates monthly 'Healthcare Affordability Accounts', boosts state reinsurance funding, and imposes sweeping price‑and‑data transparency and coverage limits.

The Brief

Senate Bill 3389 is a multipronged amendment to the Affordable Care Act and the Internal Revenue Code that (1) modifies how premium tax credits are paid (creating new ‘Healthcare Affordability Accounts’ and directing monthly advance payments into them for a limited period); (2) extends and phases down enhanced premium subsidies adopted after 2020; (3) tightens enrollment verification and directs Exchanges to facilitate enrollment into the new accounts; and (4) creates major federal requirements and penalties for price and coverage transparency across hospitals, clinical laboratories, imaging providers, and ambulatory surgical centers.

The bill simultaneously imposes explicit coverage exclusions—barring qualified health plans from covering gender transition procedures and denying federal support for plans that cover abortion (with narrow exceptions)—and it expands state flexibility by streamlining and funding section 1332 waivers for reinsurance or “invisible” high‑risk pools. Practically, S.3389 aims to change where subsidy dollars flow and to generate more public price data; it also creates significant operational, compliance, and contractual work for insurers, providers, ERISA plan sponsors, PBMs and state regulators.

At a Glance

What It Does

Redirects advance premium tax credits into newly created Healthcare Affordability Accounts (an HSA‑style vehicle) for plan years starting after Dec. 31, 2026 (through specified sunset years), requires Exchanges to facilitate enrollment, extends enhanced ARPA‑style subsidies through 2031 with a multi‑year phase‑down, and adds machine‑readable price disclosure and enforcement requirements for hospitals, labs, imaging, and ambulatory surgical centers. It also adds biometric ID verification for Marketplace enrollment and creates new guardrails and grants for State reinsurance/invisible high‑risk pools under section 1332.

Who It Affects

Affected parties include individual market issuers and Exchanges, hospitals and health systems, clinical diagnostic laboratories, imaging centers, ambulatory surgical centers, ERISA plan sponsors and administrators, pharmacy benefit managers, and State insurance regulators and Medicaid/basic health program administrators.

Why It Matters

The bill shifts subsidy mechanics (monthly Treasury deposits into consumer accounts), expands federal transparency and data‑access requirements with civil penalties, and pumps targeted federal dollars into State reinsurance programs. Those moves could lower premiums in some markets but impose substantial implementation, data, and contract changes across payers and providers and raise legal and privacy questions about coverage limits and federal‑state interactions.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

S.3389 is a hybrid package of tax, exchange, coverage, transparency, and waiver reforms. On subsidies, the bill creates a temporary architecture to channel advance premium tax credits into a new class of health savings account—called a Healthcare Affordability Account (HAA)—for plan years beginning after December 31, 2026 (subject to the bill’s specified sunset windows).

The Exchanges must facilitate enrollment and link applicants to Treasury’s HAA enrollment application; Treasury is required to deposit advance premium tax credits periodically (monthly or other periodic basis) into the HAA. The bill also adds a minimum ‘monthly premium payment’ floor (tiered $10–$40 by income bracket) to the premium assistance calculation and extends enhanced premium credits through 2031 while specifying a phasedown schedule for the enhanced portion.

On coverage, the bill inserts two distinct sets of limits: it bars use of HAA funds for abortion and for a broadly enumerated list of gender transition procedures; it separately requires qualified health plans not to provide coverage for gender transition procedures and excludes the portion of a plan’s premium allocable to abortion coverage from premium tax credit calculations. For abortion the bill also conditions CSR and appropriation flows—directing that funds appropriated for CSR cannot be used to subsidize plans that include abortion, except when the mother’s life is endangered or the pregnancy resulted from rape or incest.Transparency and consumer access form the other large block.

Hospitals must publish machine‑readable standard charges and consumer‑friendly price lists that cover at least 300 shoppable services then all shoppable services after a phase‑in, including payer‑specific negotiated rates and discounted cash prices; a senior executive must attest to accuracy. Clinical labs, imaging providers, and ambulatory surgical centers face parallel machine‑readable disclosure rules, monthly or annual update cadence, and civil penalties for noncompliance.

The bill also strengthens coverage transparency and Explanation of Benefits requirements—requiring real‑time self‑service estimators, monthly machine‑readable rate files from health plans, itemized bills to patients within 30 days after final payment, and protections that block collections until requirements are met.Finally, the bill expands State flexibility under section 1332: it streamlines the waiver application and approval timelines (including an expedited 45‑day process for some waivers), authorizes substantial grant funding for invisible high‑risk pools and reinsurance ($500M for FY2027 and $5B per year FY2028–2030) and allows States to request their federal pass‑through funds be paid to the State to operate reinsurance or invisible pools without counting those grant amounts against budget‑neutrality calculations. The legislation also tightens access to claims and pricing data for group health plans and prohibits contractual gag clauses between plans and third‑party administrators, imposing hefty penalties for non‑compliance.

The Five Things You Need to Know

1

Section 101 imposes a minimum monthly premium payment floor used in the premium assistance formula: $10 for households under 200% FPL; $20 for 200–299% FPL; $30 for 300–399% FPL; $40 for 400%+ FPL.

2

For plan years starting after Dec. 31, 2026 and before Jan. 1, 2032 the bill requires advance premium tax credits to be paid into Treasury‑maintained Healthcare Affordability Accounts (an HSA‑style account) and directs Treasury to make those deposits on a monthly (or periodic) basis.

3

The bill extends enhanced ARPA‑style premium subsidies through taxable year 2031 but phases down the enhanced amount in steps (20% reduction beginning in 2028, 40% in 2029, 60% in 2030, and 80% in 2031).

4

Hospitals must publish machine‑readable standard charges and a consumer‑facing price list covering at least 300 shoppable services (phase‑in), include payer‑specific negotiated rates and discounted cash prices, and face per‑day and per‑bed civil monetary penalties (scalable to multi‑million dollars for persistent noncompliance).

5

Section 111 creates expedited and streamlined 1332 waiver rules and appropriates money for State reinsurance/invisible high‑risk pools (initial allocation guidance, $500M for FY2027, and $5B per year for FY2028–2030), and allows States to receive pass‑through federal funds for these programs without counting those grants against waiver budget‑neutrality calculations.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Sec. 101

Minimum monthly premium payments

This provision amends IRC §36B to add a built‑in minimum monthly premium payment that the premium assistance amount cannot reduce below. The amounts are small flat floors tied to income bands ($10–$40). Mechanically this raises a floor on enrollee contribution in the premium‑tax‑credit math; administrators and Exchange calculators must incorporate those floors when computing monthly APTC entitlements.

Secs. 102–105, 103–104

Healthcare Affordability Accounts and subsidy mechanics

The bill creates a new HSA‑style vehicle called a Healthcare Affordability Account (HAA) via a new IRC §223(i) and requires Treasury to deposit advance premium tax credits into those accounts for specified plan years. Exchanges must notify and facilitate HAA enrollment for premium credit‑eligible consumers; Treasury performs monthly (or periodic) transfers. The HAA rules restrict permitted uses (explicitly excluding abortion and an enumerated list of gender transition procedures), allow rollovers of existing HSAs into the HAA only at establishment, and prevent rollovers out of the HAA to other HSAs. Compliance work includes updating enrollment workflows, toggling premium payments, and reconciling APTC flows between Treasury, Exchanges, insurers and consumers.

Secs. 105 & 105(iv)

Extension and phasedown of enhanced premium credits

The bill carries forward enhanced subsidy rules (the ARPA temporary expansions) through 2031, but it adds a statutory phasedown schedule that reduces the enhanced portion incrementally beginning in 2028. Systems that compute expected APTC must implement the new higher income threshold (temporarily up to 700% FPL in certain years) and the stepwise reduction percentages; tax‑year and plan‑year alignment, and IRS/Exchange coordination, are necessary for correct year‑by‑year application.

5 more sections
Secs. 106–110

Coverage limits on abortion and gender transition; CSR funding

The bill forbids HAA funds from being used for abortions and specifically excludes gender transition procedures from qualified health plan coverage. It also adjusts the premium‑credit rules to remove plan portions attributable to abortion from credit calculations and conditions CSR appropriations so payments cannot fund plans covering abortion except in narrow exceptions (life of mother, rape/incest). Operationally this requires issuers to carve out and itemize premium portions attributable to prohibited coverages, update plan benefit templates and CMS reporting, and change IRS/Exchange reporting and reconciliation.

Sec. 111

State waivers, reinsurance grants, and expedited approvals

The bill redesigns section 1332 waiver processes: it allows Governors to submit certifications instead of legislative changes, shortens review timelines (45 days for expedited cases), creates provisional approvals (3‑year) with later full approvals up to 6 years, and explicitly authorizes substantial federal grants for invisible high‑risk pools and reinsurance. The legislation establishes allocation methodology, appropriates $500M for FY2027 and $5B per year for FY2028–2030, and permits States to receive pass‑through funds for reinsurance without counting those dollars in budget‑neutrality calculations—changing the practical calculus for waiver designers and budget offices.

Title II — Secs. 201–205

Hospital, lab, imaging, and ASC price transparency and plan data files

Title II dramatically expands transparency mandates: hospitals must publish machine‑readable standard charges and consumer‑facing price data (payer‑specific negotiated rates, discounted cash prices), and attest to accuracy with yearly monitoring and civil penalties tied to bed count and persistence. Clinical labs, imaging providers, and ambulatory surgical centers face parallel disclosure duties with defined update frequencies. Separately, health plans must post three machine‑readable rate/payment files monthly (in standardized formats) that include contracted in‑network rates, historical net drug prices, and out‑of‑network billed/allowed amounts; the bill prescribes audits, usability standards, and substantial plan penalties for deficient files.

Secs. 206–207

Group plan access to claims/pricing data and ASP oversight

The bill prohibits contract clauses that prevent group health plans, sponsors, administrators or auditors from accessing claims, encounter data, contract pricing methodologies, and reconciliation records. It prescribes electronic formats (ASC X12N 837/835, NCPDP), demands real‑time or quarterly data availability, and applies civil monetary penalties for violations. It also adds a new federal oversight regime for administrative service providers (ASPs/TPAs), requiring routine disclosure of rebates, fee structures, and value‑based payment reconciliations so plan fiduciaries can audit and verify payments.

Secs. 209–210

Explanation of benefits and itemized bills

The bill tightens patient‑facing information: EOBs and advance good‑faith estimates must include CPT/HCPCS/NDC codes, site of service, incurred deductible/out‑of‑pocket totals and any frequency limits; plans must provide real‑time self‑service estimators and hold members harmless for estimator underpayments. Providers must deliver itemized bills within 30 days after final payment and cannot pursue collections if an itemized bill wasn’t provided or if charges exceed a compliant good faith estimate unless the provider documents unforeseeable medical necessity—shifting many collection and billing processes.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Healthcare across all five countries.

Explore Healthcare in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Low‑ and moderate‑income Marketplace enrollees — temporary extension and higher subsidy thresholds plus monthly deposits into HAAs increase short‑term purchasing power and give enrollees account balances to manage premiums and cost‑sharing.
  • States with fragile individual markets — the dedicated 1332 grant pool and flexible authorization to use pass‑through funds for reinsurance or invisible high‑risk pools gives states federal capital to stabilize premiums and attract carriers.
  • Employers and ERISA plans (fiduciaries) — stronger access to claims, encounter, pricing and contract documentation makes audit, oversight and negotiation with vendors (TPAs, PBMs, networks) more effective.
  • Cash‑paying patients and price‑conscious consumers — explicit discounted cash‑price acceptance and richer machine‑readable price data increase ability to compare costs and negotiate or seek lower‑cost sites of care.

Who Bears the Cost

  • Hospitals, clinical labs, imaging centers and ambulatory surgical centers — must build, maintain and attest to machine‑readable price files, support consumer tools and compliance programs, and face potentially large civil penalties for noncompliance.
  • Insurers and third‑party administrators — need system changes to accept HAA payment flows, produce monthly machine‑readable rate files, implement new Exchange and Treasury interfaces, and renegotiate provider contracts where contract terms must be disclosed.
  • Providers of abortion and gender‑affirming services — practical and financial access is reduced where plans lose federal credits/CSR support and HAAs prohibit use of subsidy funds for those services.
  • PBMs and vendor intermediaries — face new disclosure requirements for rebates, fees and alternative payments, threatening proprietary revenue streams and creating renegotiation of longstanding contracts.
  • State and federal regulators and IT teams — will incur administrative and technical costs standing up expedited waiver reviews, allocation methodologies, audit programs and public file repositories.

Key Issues

The Core Tension

S.3389 forces a tradeoff between two legitimate goals: making health coverage cheaper and more transparent, versus preserving broad benefit access and existing contractual confidentiality. The bill levers subsidy flow and state reinsurance to lower premiums and nails down consumer‑facing price information; at the same time it narrows federally funded coverage (abortion and gender‑affirming care) and compels disclosure of negotiated commercial terms—measures that reduce some costs but raise privacy, legal and access‑for‑care concerns with no one‑size‑fits‑all resolution.

The bill bundles affordability tools with coverage restrictions and aggressive transparency mandates, producing a set of real trade‑offs. Redirecting advance premium tax credits into consumer accounts changes cash‑flow dynamics: issuers, Exchanges and Treasury must coordinate monthly transfers, reconcile accounts, and handle lapses and repayments.

That logistical change can improve consumer control but creates timing, systems and counterparty risk—especially if issuer premium receipts drop or if state premium tax structures aren’t aligned. The HAA design also raises questions about eligibility verification, account administration, and whether account balances will meaningfully reduce out‑of‑pocket exposure for high‑cost consumers.

Transparency and data access provisions advance consumer information but impose nontrivial compliance costs and contractual upheaval. Machine‑readable rate files and attestation requirements force providers and plans to disclose negotiated rates and contract formulas—items often treated as commercially sensitive—creating potential litigation and pushback.

The bill tries to preserve HIPAA compliance but implementing the standard formats, audit regimes, and real‑time exchange of claims/835/ERA files will require substantial vendor and IT work. Finally, the coverage exclusions for abortion and gender transition services create two implementation headaches: (1) benefit design and premium allocation mechanics require issuers to separately price and report those coverages for credit exclusion and CSR rules, and (2) the provisions risk collision with state laws that require or protect such coverage and with nondiscrimination standards, setting up litigation and state‑federal tension.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.